Reading the tape
NASDAQ: BTMD
biote Corp.
Healthcare · Medical - Care Facilities
Market Cap
$96.37M
52w High
$4.75
52w Low
$1.27
P/E
2.48
Volume
137.40K
Outstanding Shares
44.11M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -32.62%Revenue (TTM): -2.52%FCF (TTM): -21.68%P/FCF: 0th pct
What changed
The stock fell 32.62% over the last year. Revenue declined 2.52% over the trailing twelve months. Operating margin moved from 16.03% to 18.5%. Free cash flow declined 21.68% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 18.5%. A decisive move in revenue — currently down 2.52% — would be the clearest signal to resolve the ambiguity.
Company profile
biote Corp. operates in medical practice-building business within the hormone optimization space.
CEOBret Christensen
SectorHealthcare
IndustryMedical - Care Facilities
Employees217
IPO dateApr 28, 2021
Valuation
Forward P/E—
EV/EBITDA4.26
Enterprise value$167.14M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-6.87%
Gross margin71.46%▲1.33%vs FY2024
Operating margin18.5%▲15.37%vs FY2024
ROE-46.2%▼1450.16%vs FY2024
Analyst consensus
RatingBuy
Target price$3.25▲48.74%
6
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est $0.09 · Revenue est $46.02M
View